Exchange Traded Concepts, LLC Altimmune, Inc. Transaction History
Exchange Traded Concepts, LLC
- $7.62 Billion
- Q2 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 175,707 shares of ALT stock, worth $722,155. This represents 0.01% of its overall portfolio holdings.
Number of Shares
175,707
Previous 153,606
14.39%
Holding current value
$722,155
Previous $768,000
11.59%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ALT
# of Institutions
204Shares Held
37.8MCall Options Held
2MPut Options Held
1.69M-
Black Rock Inc. New York, NY5.32MShares$21.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$18.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$13.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$11.3 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$7.01 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $201M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...